Iwaniak, P.; Dobrowolski, P.; Wróbel, J.; Kluz, T.; Wdowiak, A.; Bojar, I.; Stangel-Wójcikiewicz, K.; Poleszak, E.; Jakimiuk, A.; Misiek, M.;
et al. The Assessment of the Efficacy of Imperatorin in Reducing Overactive Bladder Symptoms. Int. J. Mol. Sci. 2023, 24, 15793.
https://doi.org/10.3390/ijms242115793
AMA Style
Iwaniak P, Dobrowolski P, Wróbel J, Kluz T, Wdowiak A, Bojar I, Stangel-Wójcikiewicz K, Poleszak E, Jakimiuk A, Misiek M,
et al. The Assessment of the Efficacy of Imperatorin in Reducing Overactive Bladder Symptoms. International Journal of Molecular Sciences. 2023; 24(21):15793.
https://doi.org/10.3390/ijms242115793
Chicago/Turabian Style
Iwaniak, Paulina, Piotr Dobrowolski, Jan Wróbel, Tomasz Kluz, Artur Wdowiak, Iwona Bojar, Klaudia Stangel-Wójcikiewicz, Ewa Poleszak, Artur Jakimiuk, Marcin Misiek,
and et al. 2023. "The Assessment of the Efficacy of Imperatorin in Reducing Overactive Bladder Symptoms" International Journal of Molecular Sciences 24, no. 21: 15793.
https://doi.org/10.3390/ijms242115793
APA Style
Iwaniak, P., Dobrowolski, P., Wróbel, J., Kluz, T., Wdowiak, A., Bojar, I., Stangel-Wójcikiewicz, K., Poleszak, E., Jakimiuk, A., Misiek, M., Zapała, Ł., & Wróbel, A.
(2023). The Assessment of the Efficacy of Imperatorin in Reducing Overactive Bladder Symptoms. International Journal of Molecular Sciences, 24(21), 15793.
https://doi.org/10.3390/ijms242115793